In vivo reduction of the nuclear factor-κB activity using synthetic cis-element decoy oligonucleotides suppresses intimal hyperplasia in the injured carotid arteries in rabbits

Surgery Today

Volumn 37, Issue 7, 2007, Pages 575-583

  Takeuchi, Kensuke ^a,c   Itoh, Hiroyuki ^a   Yonemitsu, Yoshikazu ^a   Matsumoto, Takuya ^a   Kume, Masazumi ^a   Komori, Kimihiro ^b   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Arita Kyouritsu Hospital   (Japan)

Author keywords

Decoy; HVJ liposomes; Intimal hyperplasia; Nuclear factor B (NF B); Restenosis

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOTHIOCYANIC ACID; LIPOSOME; OLIGONUCLEOTIDE; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CAROTID ARTERY; CAROTID ARTERY INJURY; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE; GEL MOBILITY SHIFT ASSAY; HYPERPLASIA; NONHUMAN; PARAINFLUENZA VIRUS 1; PROTEIN EXPRESSION; PROTEIN FUNCTION; RABBIT;

ANGIOPLASTY, BALLOON; ANIMALS; APOPTOSIS; BINDING SITES; CAROTID ARTERY INJURIES; CAROTID ARTERY, COMMON; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ELECTROPHORESIS; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HYPERPLASIA; IN SITU NICK-END LABELING; INJECTIONS; MICROSCOPY, FLUORESCENCE; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; RABBITS; TUNICA INTIMA;

EID: 34347271909     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-007-3469-9     Document Type: Article

References (43)

1. DR Holmes RE Vlietstra HC Smith GW Vetrovec KM Kent MJ Cowley 1984 Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute Am J Cardiol 53 77C 81C
2. S Morimoto Y Mizuno S Hiramatsu K Yamada N Kudo M Nomura 1990 Restenosis after percutaneous transluminal coronary angioplasty-a histopathological study using autopsied hearts Jpn Circ J 54 43 56
3. PE Karayannacos JR Hostetler MG Bond GS Kakos RA Williams JW Kilman 1978 Late failure in vein grafts: mediating factors in subendothelial fibromuscular hyperplasia Ann Surg 187 183 8
4. H Itoh K Komori T Onohara S Funahashi K Okadome K Sugimachi 1995 Late graft failure of autologous vein grafts for arterial occlusive disease: clinical experimental studies Surg Today 25 293 8
5. RE Bellas JS Lee GE Sonenshein 1995 Expression of a constitutive NF-κB-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells J Clin Invest 96 2521 7
6. S Grimm PA Baeuerle 1993 The inducible transcription factor NF-κB: structure-function relationship of its protein subunits Biochem J 290 Pt 2 297 308
7. K Brand S Page G Rogler A Bartsch R Brandl R Knuechel 1996 Activated transcription factor nuclear factor-κB is present in the atherosclerotic lesion J Clin Invest 97 1715 22
8. B Cercek M Yamashita P Dimayuga J Zhu MC Fishbein S Kaul 1997 Nuclear factor-κB activity and arterial response to balloon injury Atherosclerosis 131 59 66
9. BA Sullenger HF Gallardo GE Ungers E Gilboa 1990 Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication Cell 63 601 8
10. A Bielinska RA Shivdasani LQ Zhang GJ Nabel 1990 Regulation of gene expression with double-stranded phosphorothioate oligonucleotides Science 250 997 1000
11. R Morishita GH Gibbons M Horiuchi KE Ellison M Nakama L Zhang 1995 A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo Proc Natl Acad Sci USA 92 5855 9
12. R Morishita T Sugimoto M Aoki I Kida N Tomita A Moriguchi 1997 In vivo transfection of cis element "decoy" against nuclear factor-κB binding site prevents myocardial infarction Nat Med 3 894 9
13. KM Ryan MK Ernst NR Rice KH Vousden 2000 Role of NF-κB in p53-mediated programmed cell death Nature 404 892 7
14. JF Schmedtje YS Ji WL Liu RN DuBois MS Runge 1997 Hypoxia induces cyclooxygenase-2 via the NF-κB p65 transcription factor in human vascular endothelial cells J Biol Chem 272 601 8
15. T Yamada M Horiuchi R Morishita L Zhang RE Pratt VJ Dzau 1995 In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer J Clin Invest 96 1230 7
16. FD di Fagagna G Marzio MI Gutierrez LY Kang A Falaschi M Giacca 1995 Molecular and functional interactions of transcription factor USF with the long terminal repeat of human immunodeficiency virus type 1 J Virol 69 2765 5
17. H Tanaka P Vickart JR Bertrand B Rayner F Morvan JL Imbach 1994 Sequence-specific interaction of alpha-beta-anomeric double-stranded DNA with the p50 subunit of NF-κB: application to the decoy approach Nucleic Acid Res 22 3069 74
18. HW Sharma JR Perez K Higgins-Sochaski R Hsiao R Narayanan 1996 Transcription factor decoy approach to decipher the role of NF-κB in oncogenesis Anticancer Res 16 61 9
19. R Morishita GH Gibbons Y Kaneda T Ogihara VJ Dzau 1994 Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery Gene 149 13 9
20. S Hoshi M Goto N Koyama K Nomoto H Tanaka 2000 Regulation of vascular smooth muscle cell proliferation by nuclear factor-κB and its inhibitor, I-κB J Biol Chem 275 883 9
21. Y Yonemitsu Y Kaneda R Morishita K Nakagawa Y Nakashima K Sueishi 1996 Characterization of in vivo gene transfer into the arterial wall mediated by the Sendai virus (hemagglutinating virus of Japan) liposomes: an effective tool for the in vivo study of arterial diseases Lab Invest 75 313 23
22. M Igase T Okura Y Kitami K Hiwada 1999 Apoptosis and Bcl-xs in the intimal thickening of balloon-injured carotid arteries Clin Sci 96 605 12
23. MR Bennett 1999 Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture Cardiovasc Res 41 361 8
24. RW Clarkson JL Heeley R Chapman F Aillet RT Hay A Wyllie 2000 NF-κB inhibits apoptosis in murine mammary epithelia J Biol Chem 275 12737 42
25. H Yasukawa T Imaizumi H Matsuoka A Nakashima M Morimatsu 1997 Inhibition of intimal hyperplasia after balloon injury by antibodies to intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 Circulation 95 1515 22
26. I Maruyama K Shigeta H Miyahara T Nakajima H Shin S Ide Kitajima I. Thrombin 1997 activates NF-κB through thrombin receptor and results in proliferation of vascular smooth muscle cells: role of thrombin in atherosclerosis and restenosis Ann NY Acad Sci 811 429 36
27. T Marumo VB Schini-Kerth B Fisslthaler R Busse 1997 Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-κB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells Circulation 96 2361 7
28. VM Byrd DW Ballard GG Miller JW Thomas 1999 Fibroblast growth factor-1 (FGF-1) enhances IL-2 production and nuclear translocation of NF-κB in FGF receptor-bearing Jurkat T cells J Immunol 162 5853 9
29. T Nakajima I Kitajima H Shin I Takasaki K Shigeta K Abeyama 1994 Involvement of NF-κB activation in thrombin-induced human vascular smooth muscle cell proliferation Biochem Biophys Res Commun 28 204 950 8
30. MV Autieri TL Yue GZ Ferstein E Ohlstein 1995 Antisense oligonucleotides to the p65 subunit of NF-κB inhibit human vascular smooth muscle cell adherence and proliferation and prevent neointima formation in rat carotid arteries Biochem Biophys Res Commun 213 827 36
31. K Katsuyama M Shichiri F Marumo Y Hirata 1998 NO inhibits cytokine-induced iNOS expression and NF-κB activation by interfering with phosphorylation and degradation of IκB-alpha Arterioscler Thromb Vasc Biol 18 1796 802
32. H Tomita K Egashira M Kubo-Inoue M Usui M Koyanagi H Shimokawa 1998 Inhibition of NO synthesis induces inflammatory changes and monocyte chemoattractant protein-1 expression in rat hearts and vessels Arteriscler Thromb Vasc Biol 18 1456 64
33. Y Yonemitsu Y Kaneda K Komori K Hirai K Sugimachi K Sueishi 1997 The immediate early gene of human cytomegalovirus stimulates vascular smooth muscle cell proliferation in vitro and in vivo Biochem Biophys Res Commun 231 447 51
34. A Kol G Sperti J Shani N Schulhoff W Vandegreef MP Landini 1995 Cytomegalovirus replication is not a cause of instability in unstable angina Circulation 91 1910 3
35. S Tanaka Y Toh R Mori K Komori K Okadome K Sugimachi 1992 Possible role of cytomegalovirus in the pathogenesis of inflammatory aortic diseases: a preliminary report J Vasc Surg 16 274 9
36. S Tanaka K Komori K Okadome K Sugimachi R Mori 1994 Detection of active cytomegalovirus infection in inflammatory aortic aneurysms with RNA polymerase chain reaction J Vasc Surg 20 235 43
37. Y Yonemitsu K Nakagawa S Tanaka R Mori K Sugimachi K Sueishi 1996 In situ detection of frequent and active infection of human cytomegalovirus in inflammatory abdominal aortic aneurysms: possible pathogenic role in sustained chronic inflammatory reaction Lab Invest 74 723 36
38. Y Yonemitsu 1998 Viruses and vascular disease Nat Med 4 253 4
39. T Matsumoto K Komori Y Yonemitsu R Morishita K Sueishi Y Kaneda 1998 Hemagglutinating virus of Japan-liposome-mediated gene transfer of endothelial cell nitric oxide synthase inhibits intimal hyperplasia of canine vein grafts under conditions of poor runoff J Vasc Surg 27 135 44
40. DX Bu W Erl R de Martin GK Hansson Yan ZQ. IKKbeta-dependent 2005 NF-kappaB: pathway controls vascular inflammation and intimal hyperplasia FASEB J 19 1293 5
41. S Kaul B Cercek J Rengstrom XP Xu MD Molloy P Dimayuga 2000 Polymeric-based perivascular delivery of a nitric oxide donor inhibits intimal thickening after balloon denudation arterial injury: role of nuclear factor-kappaB J Am Coll Cardiol 35 493 501
42. M Mazighi A Pelle W Gonzalez M Mtairagel M Philippe D Henin 2004 IL-10 inhibits vascular smooth muscle cell activation in vitro and in vivo Am J Physiol Heart Circ Physiol 287 866 71
43. BS Zuckerbraun CA McCloskey RS Mahidhara PK Kim BS Taylor E Tzeng 2003 Overexpression of mutated IκBα inhibits vascular smooth muscle cell proliferation and intimal hyperplasia formation J Vasc Surg 38 812 9